Skip to main content

Enasidenib gets FDA approval for AML with IDH2 mutations

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Enasidenib gets FDA approval for AML with IDH2 mutations

User login

Username

Password

Reset your password

Type	Lead	score